It is illegal to advertise prescription-only weight loss drugs and Ms Collins' was one of nine adverts banned in a crackdown ...

The weight loss drug Wegovy may do more than help people lose weight New trial results show the weight-loss medication Wegovy can also cut heart attack and stroke risks, according to the drug's maker.

Thousands of people who used a weight-loss supplement will be receiving a portion of more than $400,000, according to the ...

Compounded weight loss drugs have been mostly off the market for about a month, but the weight loss drug industry remains as unsettled as ever. Earlier this week, Novo Nordisk tore up a partnership ...

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...

And Lilly’s other weight loss drug, tirzepatide, was shown to reduce body weight, on average, by 22.5% on average, or about 52 pounds, after 72 weeks.

For example, Medicare does not cover weight loss medication, though it covers counseling and weight loss surgery for those of a certain BMI. However, if approved, the drug is expected to do well.

The decision by the Food and Drug Administration on Wednesday to approve the weight loss drug tirzepatide adds a potent new tool to the fast-growing arsenal of obesity drugs.. The drug, which will ...

In trials of Wegovy, up to 40% of weight loss was from a decrease in lean or fat-free mass, rather than excess fat. In addition, quitting the drugs can mean adding back the pounds.

This weight loss drug can reduce your migraine days by half — it’s not Ozempic By . McKenzie Beard. Published June 25, 2025, 10:17 a.m. ET.

In 2023, the FDA will likely approve Eli Lilly's diabetes drug tirzepatide for weight loss — but there's little indication insurers will widely cover the medication. IE 11 is not supported.